• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

    12/4/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials
    Get the next $CC alert in real time by email

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/

    Chemours appoints Michael Foley as President of Titanium Technologies

    Chemours appoints Michael Foley as President of Titanium Technologies

    Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects Chemours' ongoing commitment to advancing its TT value-based business strategy. During this period, Chemours President and CEO Denise Dignam will provide leadership support to ensure continuity and continued progress on TT's transformation journey.

    Michael Foley joins Chemours with extensive leadership experience in the chemical industry. Most recently, he served as President & General Manager of the Formulated Specialties Business at Momentive Performance Materials, overseeing a $1 billion portfolio across five business units, eight manufacturing sites, and 2,000 employees worldwide. His career includes transformative roles in portfolio optimization, organizational restructuring, and operational excellence at Momentive, as well as leadership positions at General Electric, where he was recognized for expertise in Lean and Six Sigma methodologies. Mr. Foley holds a Bachelor of Science in Environmental Engineering and an MBA from Rensselaer Polytechnic Institute.

    "We are excited to welcome Michael Foley to Chemours as President of Titanium Technologies," said Denise Dignam, President and CEO of Chemours. "Michael's proven track record of strategic transformation and operational leadership will be instrumental as we continue to advance our TT business and deliver value for our customers, partners, and shareholders."

    "I look forward to joining Chemours and leading the Titanium Technologies team. TT has a strong foundation and clear strategy to deliver value, and I'm eager to work with this talented team to drive innovation, strengthen partnerships, and create sustainable value for our stakeholders," added Foley.

    Chemours Titanium Technologies is one of the world's largest manufacturers of titanium dioxide (TiO₂), serving the global coatings, laminates, and plastics markets. The company remains focused on delivering strong business results and executing its Pathway to Thrive strategy.

    About The Chemours Company

    The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,000 employees and 28 manufacturing sites and serves approximately 2,500 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn.

    Forward-Looking Statements

    This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the advancement of our growth strategy and the impact of individual expertise on the company's strategy and performance, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions and global health events, have affected or may affect our business and operations and may or may not continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission (the "SEC"), including in our Annual Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251204540269/en/

    INVESTORS

    Brandon Ontjes

    VP, Head of Strategy & Investor Relations

    +1.302.773.3300

    [email protected]



    NEWS MEDIA

    Cassie Olszewski

    Media Relations & Reputation Leader

    +1.302.219.7140

    [email protected]

    Get the next $CC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CC

    DatePrice TargetRatingAnalyst
    3/27/2025$19.00Neutral → Outperform
    Mizuho
    1/28/2025$27.00Buy
    Truist
    7/9/2024$28.00 → $30.00Neutral → Buy
    UBS
    6/7/2024$25.00Neutral
    Mizuho
    4/9/2024$19.00 → $34.00Underperform → Outperform
    BMO Capital Markets
    3/5/2024$37.00 → $21.00Buy → Neutral
    UBS
    2/29/2024$45.00 → $19.00Outperform → Underperform
    BMO Capital Markets
    12/1/2023$28.00 → $40.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $CC
    SEC Filings

    View All

    SEC Form 10-Q filed by Chemours Company

    10-Q - Chemours Co (0001627223) (Filer)

    11/6/25 4:34:47 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Chemours Co (0001627223) (Filer)

    11/6/25 4:32:10 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Chemours Co (0001627223) (Filer)

    10/31/25 4:32:48 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/Chemours appoints Michael Foley as President of Titanium Technologies Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects C

    12/4/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Fourth Quarter Dividend

    The Chemours Company ("Chemours") (NYSE:CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2025. The dividend will be paid on December 15, 2025, to stockholders of record as of the close of business on November 14, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Speciali

    10/29/25 5:00:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2025 financial results after market on Thursday, November 6, 2025. The Company expects to hold its conference call to discuss its third quarter 2025 financial results at 8:00 a.m. Eastern Time on Friday, November 7, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please visit inves

    10/16/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Satterthwaite Livingston

    4 - Chemours Co (0001627223) (Issuer)

    10/2/25 10:42:02 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form 4 filed by Director Mather Courtney

    4 - Chemours Co (0001627223) (Issuer)

    10/2/25 10:38:19 AM ET
    $CC
    Major Chemicals
    Industrials

    Pres Advanced Performance Mat Familiar Calderon Gerardo covered exercise/tax liability with 1,294 shares, decreasing direct ownership by 4% to 33,950 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    9/3/25 7:52:40 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Leadership Updates

    Live Leadership Updates

    View All

    Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/Chemours appoints Michael Foley as President of Titanium Technologies Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects C

    12/4/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Appoints Matthew Conti as Chief Human Resources Officer

    Seasoned HR executive supports Chemours' Pathway to Thrive strategy The Chemours Company (Chemours) (NYSE:CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612880421/en/Chemours appoints Matthew Conti as Chief Human Resource

    6/12/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

    The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of technology and data center experience, his addition reinforces Chemours' commitment to driving near- and long-term growth in the liquid cooling market. Bringing over two decades of experience in executive leadership, business transformation, and go-to-market strategy across the technology and data center infrastructure sectors, Blom is a strong addition to Chemours leadership. The appointment supports the company's "Pathway to Thrive" strategy, with liquid cooling representing a ke

    6/10/25 6:45:00 AM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Financials

    Live finance-specific insights

    View All

    Chemours Announces Fourth Quarter Dividend

    The Chemours Company ("Chemours") (NYSE:CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2025. The dividend will be paid on December 15, 2025, to stockholders of record as of the close of business on November 14, 2025. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Speciali

    10/29/25 5:00:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2025 financial results after market on Thursday, November 6, 2025. The Company expects to hold its conference call to discuss its third quarter 2025 financial results at 8:00 a.m. Eastern Time on Friday, November 7, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please visit inves

    10/16/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call

    The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2025 financial results after market on Tuesday, August 5, 2025. The Company expects to hold its conference call to discuss its second quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, August 6, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please vi

    7/29/25 4:30:00 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Chemours Company

    SC 13G/A - Chemours Co (0001627223) (Subject)

    11/12/24 9:55:16 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Chemours Company (Amendment)

    SC 13G/A - Chemours Co (0001627223) (Subject)

    2/9/24 8:50:19 AM ET
    $CC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Chemours Company (Amendment)

    SC 13G/A - Chemours Co (0001627223) (Subject)

    1/24/24 9:46:44 AM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Dignam Denise bought $49,060 worth of shares (4,068 units at $12.06) (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    8/12/25 5:12:16 PM ET
    $CC
    Major Chemicals
    Industrials

    Officer Gumpel Damian bought $201,376 worth of shares (21,222 units at $9.49), increasing direct ownership by 19% to 131,701 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    6/4/25 8:32:18 PM ET
    $CC
    Major Chemicals
    Industrials

    Chief Financial Officer Hostetter Shane bought $50,196 worth of shares (4,450 units at $11.28), increasing direct ownership by 8% to 59,694 units (SEC Form 4)

    4 - Chemours Co (0001627223) (Issuer)

    5/21/25 5:13:57 PM ET
    $CC
    Major Chemicals
    Industrials

    $CC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chemours upgraded by Mizuho with a new price target

    Mizuho upgraded Chemours from Neutral to Outperform and set a new price target of $19.00

    3/27/25 8:05:02 AM ET
    $CC
    Major Chemicals
    Industrials

    Truist initiated coverage on Chemours with a new price target

    Truist initiated coverage of Chemours with a rating of Buy and set a new price target of $27.00

    1/28/25 7:09:50 AM ET
    $CC
    Major Chemicals
    Industrials

    Chemours upgraded by UBS with a new price target

    UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously

    7/9/24 8:13:51 AM ET
    $CC
    Major Chemicals
    Industrials